LivaNova announced today that Marco Dolci intends to retire from his position as president of the cardiopulmonary business unit. Dolci plans to retire by Dec. 31, 2023, continuing in his role to support the transition of responsibilities through the end of the year. The company appointed Franco Poletti to serve as interim GM of cardiopulmonary […]
LivaNova
LivaNova wins FDA clearance, CE mark for Essenz in-line blood monitor
LivaNova announced today that it received FDA 510(k) clearance and CE mark for its Essenz in-line blood monitor. Essenz ILBM provides accurate and continuous measurement of essential blood parameters throughout cardiopulmonary bypass (CPB) procedures, according to LivaNova. It integrates into the next-generation Essenz perfusion system. Essenz enables perfusionists to access and manage reliable blood parameters […]
The biggest medtech personnel moves so far in 2023
Nearly a quarter of the way through 2023, we’ve seen plenty of movement in the personnel department across medtech. Last July, we broke down the biggest personnel moves in medtech so far in 2022. That was followed up by the full-year report in December. Through more than eight months, the changes atop medtech companies continue […]
LivaNova stock rises on Q2 beats, increased 2023 guidance
LivaNova shares are on the rise today on second-quarter results that came in ahead of the consensus forecast. Shares of LIVN ticked up 8.3% at $58.04 apiece in mid-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — stayed even. The London-based medtech company posted profits […]
LivaNova more than doubles profits in Q1
LivaNova (Nasdaq:LIVN) shares dipped this morning on first-quarter results that topped the consensus forecast. Shares of LIVN fell 2.4% to $45.98 apiece in mid-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — ticked up 0.5%. The London-based medtech company posted profits of 7.4 million, or […]
LivaNova CEO resigns despite revenue beat
Liva Nova CEO Damien McDonald has resigned effective immediately, with board chair William Kozy assuming interim CEO responsibilities. “As we move forward, I would like to express our gratitude on behalf of the Board to Damien McDonald for his dedicated leadership through a challenging period of Covid and unrivaled global economic disruption. We wish him […]
FDA clears Essenz heart-lung machine from LivaNova
LivaNova (Nasdaq:LIVN) announced today that it received FDA 510(k) clearance for its Essenz heart-lung machine (HLM). With clearance, the London-based company initiated its U.S. commercial launch for Essenz, too. It recently received approval for Essenz HLM from Health Canada and the Japanese Pharmaceuticals and Medical Devices Agency (PMDA). In February, LivaNova kicked off a limited […]
LivaNova grows profits in Q4 results
LivaNova (Nasdaq:LIVN) this week posted fourth-quarter results that beat the overall consensus on Wall Street. The London-based company reported profits of $1.7 million, or 3¢ per share, on sales of $274.9 million for the three months ended Dec. 31, 2022, for a sales gain of 1.78% compared with Q4 2021. It also had a profit […]
LivaNova starts limited European launch of perfusion system for cardiopulmonary bypass
LivaNova (Nasdaq:LIVN) announced today that it began a limited commercial release for its Essenz perfusion system in Europe. The company initiated its launch in select centers throughout Europe after successful implementation in The Netherlands and Italy. London-based LivaNova built the Essenz system with a next-generation heart-lung machine and a patient monitor. The company designed it […]
LivaNova launches implantable pulse generator for treating epilepsy
LivaNova (Nasdaq:LIVN) announced today that it launched its SenTiva Duo implantable pulse generator (IPG) for providing VNS Therapy. SenTiva Duo received FDA 510(k) clearance. LivaNova has made it available in the U.S. The London-based company designed its VNS Therapy as a unique approach for treating drug-resistant epilepsy. Vagus nerve stimulation (VNS) can prevent seizures before […]
LivaNova LifeSparc ACS pump cleared for extended use
LivaNova (Nasdaq: LIVN) says a new FDA clearance expands how long health providers can use its LifeSparc advanced circulatory support (ACS) pump for extracorporeal membrane oxygenation (ECMO). The new clearance makes permanent some of the temporary emergency guidelines under which LifeSparc provided ECMO therapy during the height of the COVID-19 pandemic. In a news release posted […]
